BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2010
View Archived Issues
Phase II results encourage further study of perifosine for Waldenstrom's macroglobulinemia
Read More
MF59 adjuvant induces antibody repertoire expansion to H5N1 vaccine
Read More
Alliance Pharma agrees to buy trade and certain assets of Cambridge Laboratories
Read More
FDA grants orphan drug status to Prolastin for alpha-1-antitrypsin deficiency
Read More
Phase I data show acceptable safety of BIBF-1120 in gynecological tumors
Read More
Glenmark Pharmaceuticals discovers TRPA1 antagonists for the treatment of pain
Read More
Israeli scientists disclose novel calcipotriol analogues
Read More
Merck KGaA claims novel AMP-activated protein kinase activators
Read More
Spanish scientists synthesize novel butyrylcholinesterase inhibitors
Read More
Roche and Genentech describe novel PI3K inhibitors for cancer therapy
Read More
Resveratrol may protect against vestibular hair cell death
Read More
IGF-1 hydrogels improve sensorineural hearing loss
Read More
EMEA grants orphan drug designation to AVI BioPharma's AVI-5038 in DMD
Read More
FDA approves Paloma Pharmaceutical's IND for phase I trial in AMD
Read More
FDA approves Anthera's SPA for phase III trial of A-002 in acute coronary syndrome
Read More
GeoVax presents update on development of 2-component HIV-1 vaccine
Read More
Resverlogix completes enrollment in phase II trial of RVX-208 in CAD
Read More
Avexa reports results from phase III study of apricitabine in drug-resistant HIV
Read More
Cara Therapeutics reports results of phase II CR-845 trial in acute postoperative pain
Read More
Abbott reports results from fourth quarter of 2009
Read More
Lilly's Gemzar approved in Japan for additional indication of breast cancer
Read More
Inovio Biomedica reports on phase I trial of its cervical cancer vaccine VGX-3100
Read More
Nabi completes milestone in sale of PentaStaph S. aureus vaccine to GSK
Read More
Dynavax Technologies begins phase III trial of Heplisav hepatitis B vaccine for adults
Read More
Novavax discontinues negotiations with Rovi to develop influenza vaccines
Read More